-
Vessel operator seeks witnesses after Vancouver grounding
-
Bezos grant helps Seattle nonprofit move thousands of families toward housing
-
Shrini Srivastava joins crew of Varanasi-Delhi Vande Bharat Sleeper service
-
US stocks fall before midterm Election Day as technology shares weaken
-
Nearly Half of Australian Workers Overqualified, Survey Finds
-
BLS Polymers makes strong market debut at ₹248 per share
-
RBI eases export-declaration compliance for individual service exporters
-
Petrol and diesel prices remain broadly steady across major Indian cities
-
Reliance shares remain in focus after near-12% surge
-
Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
-
Coal India prepares possible $1 billion Mahanadi Coalfields listing
-
BLS Polymers shares open 65.3% above IPO price
-
Capital-markets shares rally as Motilal Oswal and Angel One lead gains
-
ITC shares rise as analysts anticipate gradual cigarette-business recovery
-
Reliance rally puts historical one-year return pattern in focus
-
The Digital Burden: Why Instant Messaging Feels Like a Full-Time Job
-
Saudi Aramco quarterly profit climbs 34.6% amid elevated oil prices
-
Korea’s Labor Share of GDP Hits Record Low Amid Semiconductor Boom
-
Australia raises benchmark rate to highest level in 18 years
-
littlefish and Halo Dot Partner to Replace Payment Terminals with SoftPOS
-
Asian stocks retreat as AI worries outweigh steep oil-price drop
-
Egypt Accelerates Construction of 341km Sinai Railway Linking Arish and Taba
-
Hamad International Airport stages emergency drills during WATAN 2026
-
Web Summit Qatar 2026 generated QR1 billion economic impact, report says
-
Qatar solar expansion opens scope for technical performance gains
-
OMP Extends UnisonIQ with Agent Library and Agent Studio: AI Agents that Produce Executable Supply Chain Plans
S.Africa's HIV research power couple says fight goes on
Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.
Married for 36 years, the epidemiologists -- both aged 64 -- are internationally respected for their work on stopping deadly infections such as HIV/AIDS, TB and the coronavirus.
On Thursday, they received the Lasker Award for public service, a top recognition for medical research described as the US equivalent of a Nobel prize for science.
The couple have "stemmed the course of the HIV/AIDS scourge", including by launching research labs and training hundreds of scientists across Africa, the New York-based Lasker Foundation said.
They used science to dispel myth and propaganda about AIDS, it said.
The award was a "humbling moment" and "pinnacle of a research career", Salim told AFP at the Centre for the AIDS Programme of Research (Caprisa), where he is director, in the east coast city of Durban.
"Inspiring," said Quarraisha, the centre's scientific director, saying it marked "the transformative power of science being recognised, and being recognised from Africa."
The couple's focus on HIV followed their move to the United States in 1987 to work on their master's degrees at Columbia University. HIV -- first reported in 1981 -- was ravaging New York.
- HIV explosion -
"You couldn't spend a day without discussing HIV in New York," recalled Salim. When the couple returned home to South Africa, it was the "next big challenge", he said.
The country went on to record some of the highest numbers of infections in the world, becoming an epicentre of a pandemic that has claimed around 42 million lives globally, including about 3.9 million in South Africa since 1999, according to UNAIDS.
"It was in our communities, in our populations. We were trying to change behaviour around sex at a time when people didn't talk very easily about sex, when the apartheid state was also trying to control who you had sex with," said Quarraisha.
After the racially segregationist apartheid system ended in 1994, she was appointed national AIDS control programme director.
But the new government was in denial about the scale of HIV/AIDS and its poor response is estimated to have cost 2.5 million lives between 1999 and 2010, according to UNAIDS.
The Lasker Award notes: "Over the objections of the South African government, their research led to the development of the anti-retroviral treatment, Pre-Exposure Prophylaxis (PrEP), that reduced spread by 39 percent."
"They defined approaches to treat common co-infections of HIV and tuberculosis, and after five years, these deaths decreased by over 50 percent."
One of Caprisa's achievements was the pioneering of a topical gel to protect women from infection.
New infections in South Africa have dropped to 150,000 in 2023 from a peak of around 520,000 in 2000. Up to 8.3 million people in the country had the virus in 2023.
Leading causes for new infections are violence against women, young women in relationships with older men and transactional sex, Quarraisha said.
- 'Complementary perspectives' -
Salim became a household name in South Africa as a government advisor during the Covid-19 pandemic, when he was often on television giving measured advice and updates.
"If I go to the shopping mall now... people will come up to me and say, 'Thank you very much, professor'," he said.
Both born in the KwaZulu-Natal province, the couple prioritise time with their three children but have no plans to hang up their lab coats.
Quarraisha wants to see more global cooperation in public health and the development of African talent and initiative.
"When we work together, as my husband and I show, we bring different but complementary perspectives," she said. "We are able to raise the science to levels that you can't individually do."
"We are now working on some new strategies to provide long-term prevention against HIV," Salim said. "We have some really good innovations and some good research under way. It's going to keep us busy for quite a while."
A.Leibowitz--CPN